Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Principal Investigator
Name
Anton Schreuder
Degrees
M.D.
Institution
Radboudumc
Position Title
Ph.D. student
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-267
Initial CDAS Request Approval
Jan 18, 2017
Title
Risk modelling of time to lung cancer diagnosis
Summary
This project aims to predict the lung cancer risk and estimate the time frame in which the cancer diagnosis is made following a scan. The model will be developed based on participant information and baseline and followup scan outcomes.
Aims

- To determine the best predictors of developing lung cancer after a screening round based on participant characteristics and CT scan morphology.
- To observe the effect of different screening intervals.
- To ultimately predict the time frame a screening participant is likely to develop cancer in, should they develop it at all.

Collaborators

Bram van Ginneken, Diagnostic Image Analysis Group, Radboud University Medical Center Nijmegen, Netherlands
Colin Jacobs, Diagnostic Image Analysis Group, Radboud University Medical Center Nijmegen, Netherlands
Cornelia Schaefer-Prokop, MD, PhD. Radboud University Medical Center, the Netherlands
Mathias Prokop, MD, PhD. Radboud University Medical Center, the Netherlands
Max Argus, MSc. Radboud University Medical Center, the Netherlands
Anton Schreuder, MD. Radboud University Medical Center, the Netherlands

Related Publications